Evaluating drug performance, finding tomorrow's blockbusters
Drug discovery
We are expert in the discovery of antiviral molecules using imaging techniques.
Since its inception in 2014, NeoVirTech has screened thousands of compounds for their potency as antiviral molecule on the human, animal and Biodefense market.
Our discovery pipeline, from rapid investigation of compound libraries to in vivo testing in infected animals, coupled to our experience in the antiviral field, is the best combination for the success of our customer.
NeoVirTech has successfully closed multiyear antiviral screening and optimization campaign for public agencies and private companies.
Our custom R&D platform specialized in the virology field propose several level of compound testing. We can support you in the development of your antiviral molecules, from compound screening to in vivo validation:
Antiviral discovery
Our ANCHOR™ viruses are available for high-throughput imaging and screening, making it a major tool for antiviral research and development. Combined with HCS microscopy and detection algorithm, it provides the fastest and the most robust techniques to discover new antivirals.
This allows us to rapidly set up the entire pre-clinical antiviral development pipeline:
Professor Syed Haq
Dr Daniel Gillet
Enrique Tabares, CEO of MicroA A.S., Norway